Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             123 results found
no title author magazine year volume issue page(s) type
1 A.3 Rotigotine (Neupro®), a new non-ergolinic dopamine agonist in a transdermal patch, for early and late stages of Parkinson'ss Disease Giladi, N.
 2006
 12 S1 p. 4-
1 p.
 article
2 A.2 The preclinical profile of rotigotine (Neupro®), a novel non-ergolinic dopamine agonist for the transdermal treatment of Parkinson's Disease Jenner, P.
 2006
 12 S1 p. 4-
1 p.
 article
3 A.1 Unmet medical needs in the treatment of Parkinson's Disease Wolters, E.Ch.
 2006
 12 S1 p. 4-
1 p.
 article
4 Author Index 2006
 12 S1 p. 37-38
2 p.
 article
5 B.2 Dopamine agonists in the treatment of non-motor symptoms of Parkinson's Disease Lemke, M.R.
 2006
 12 S1 p. 7-
1 p.
 article
6 B.3 Risk-benefit assessment of dopamine agonists Oertel, W.H.
 2006
 12 S1 p. 7-8
2 p.
 article
7 B.1 The non-motor symptom complex of Parkinson's Disease: The Questionnaire and Scale Development Program Chaudhuri, K.R.
 2006
 12 S1 p. 7-
1 p.
 article
8 C.1 Visual hallucinations in Parkinson's Disease - cause and treatment van Laar, T.
 2006
 12 S1 p. 17-
1 p.
 article
9 I.6 Anhedonia and depression in Parkinson's Disease Reichmann, H.
 2006
 12 S1 p. 2-
1 p.
 article
10 I.8 Autonomic and sexual dysfunction in movement disorders Korczyn, A.D.
 2006
 12 S1 p. 2-3
2 p.
 article
11 I.4 Early diagnosis in PD: olfaction Berendse, H.W
 2006
 12 S1 p. 1-
1 p.
 article
12 I.5 Early diagnosis in PD: ultrasonography Berg, D.
 2006
 12 S1 p. 1-2
2 p.
 article
13 II.1 Cognitive dysfunction in early Parkinson's Disease Williams-Gray, C.
 2006
 12 S1 p. 5-
1 p.
 article
14 II.3 Dementia with Lewy bodies McKeith, I.
 2006
 12 S1 p. 5-
1 p.
 article
15 III.2 Causes for psychosis in Parkinson's Disease Giladi, N.
 2006
 12 S1 p. 9-
1 p.
 article
16 III.1 Differential diagnosis in psychosis in Parkinson's Disease patients Goetz, C.G.
 2006
 12 S1 p. 9-
1 p.
 article
17 III.10 Does deep brain stimulation for Parkinson's Disease increase depression? Roane, D.M.
 2006
 12 S1 p. 11-
1 p.
 article
18 III.6 Epidemiology and clinical aspects of depression in Parkinson's Disease Verhagen Metman, L.
 2006
 12 S1 p. 10-
1 p.
 article
19 III.4 Long term follow-up (24 months) of Quetiapine-treated Parkinson's Disease psychotic patients Rabey, J.M.
 2006
 12 S1 p. 10-
1 p.
 article
20 III.9 No change in mood but increase in apathy in Parkinson's Disease patients treated by subthalamic nucleus stimulation Lhommée, E.
 2006
 12 S1 p. 11-
1 p.
 article
21 III.5 One year follow-up study for hallucinations in patients with Parkinson's Disease Svetel, M.
 2006
 12 S1 p. 10-
1 p.
 article
22 III.P5 ACP-103 Reduces psychosis without impairing motor function in Parkinson's Disease van Kammen, D.P.
 2006
 12 S1 p. 31-
1 p.
 article
23 III.P9 Depression in Parkinson's Disease: Correlation with UPDRS parameters and comparison with spinocerebellar degeneration Kanda, F.
 2006
 12 S1 p. 32-
1 p.
 article
24 III.P8 Depression in Parkinson's Disease: overlap of features Koerts, J.
 2006
 12 S1 p. 32-
1 p.
 article
25 III.P7 Happy or sad? Semantical content interferes with emotional prosody in Parkinson's Disease Schröder, C.
 2006
 12 S1 p. 31-32
2 p.
 article
26 III.P2 Long term follow-up (24 months) of quetiapine-treated Parkinson's Disease psychotic patients Rabey, J.M.
 2006
 12 S1 p. 30-
1 p.
 article
27 III.P3 One year follow-up study for hallucinations in patients with Parkinson's Disease Svetel, M.
 2006
 12 S1 p. 30-31
2 p.
 article
28 III.P6 Regular exposure to pesticides is related to depression associated with Parkinson's Disease: Evidence from two independent Australian samples Dissanayaka, N.
 2006
 12 S1 p. 31-
1 p.
 article
29 III.P4 REM Sleep behaviour disorder predicts visual hallucinations in Parkinson's Disease Gjerstad, M.D
 2006
 12 S1 p. 31-
1 p.
 article
30 III.P11 The influence of depression on the health-related quality of life in Polish patients with moderate stage of Parkinson's Disease (PD) Boczarska-Jedynak, M.
 2006
 12 S1 p. 32-33
2 p.
 article
31 III.P10 Validity of three depression rating scales in Australian Parkinson's Disease patients Dissanayaka, N.
 2006
 12 S1 p. 32-
1 p.
 article
32 III.P1 Visual hallucinations in Parkinson's Disease; the relationship with visual processing and attention van Laar, T.
 2006
 12 S1 p. 30-
1 p.
 article
33 III.8 The influence of depression on the health-related quality of life in Polish patients with moderate stage of Parkinson'ss Disease (PD) Boczarska-Jedynak, M.
 2006
 12 S1 p. 11-
1 p.
 article
34 III.7 Treatment of depression in Parkinson's Disease Poewe, W.
 2006
 12 S1 p. 10-
1 p.
 article
35 III.3 Visual hallucinations in Parkinson's Disease; the relationship with visual processing and attention van Laar, T.
 2006
 12 S1 p. 9-
1 p.
 article
36 II.P13 Amyloid load in Parkinson's Disease Dementia (PDD) and Lewy Body Dementia (LBD) measured with 11C-PIB PET Edison, P.
 2006
 12 S1 p. 28-
1 p.
 article
37 II.2 Parkinson's disease dementia and Lewy body dementia Dubois, B.
 2006
 12 S1 p. 5-
1 p.
 article
38 II.P18 Attentional deficits affect activities of daily living in dementia associated with Parkinson's Disease Bronnick, K.
 2006
 12 S1 p. 29-
1 p.
 article
39 II.P6 Cortical [18F]FDOPA uptake and frontal cognitive functions in early Parkinson's Disease Brück, A.
 2006
 12 S1 p. 26-
1 p.
 article
40 II.P10 Cortical neuropsychological impairment differentiates Parkinson's Disease patients with and without dementia Pagonabarraga, J.
 2006
 12 S1 p. 27-
1 p.
 article
41 II.P15 DemTect: its validity to diagnose Parkinson's Disease associated dementia Gervais, C.
 2006
 12 S1 p. 28-29
2 p.
 article
42 II.P17 Different cognitive profiles in Alzheimer's disease and dementia associated with Parkinson's Disease Bronnick, K.
 2006
 12 S1 p. 29-
1 p.
 article
43 II.P3 Dopamine and fluctuation of attention in Parkinson's Disease Correa-Neto, Y.
 2006
 12 S1 p. 25-
1 p.
 article
44 II.P5 Effects of Parkinson Disease (PD) laterality on spatial working memory performance Foster, E.
 2006
 12 S1 p. 26-
1 p.
 article
45 II.P9 Emotional processing in Parkinson's Disease: correlation of cognitive functions‚ motor impairment and mood changes Möbes, J.
 2006
 12 S1 p. 27-
1 p.
 article
46 II.P11 Executive dysfunction and frontostriatal circuits in Parkinson's Disease: A fMRI study Reuter, I.
 2006
 12 S1 p. 27-
1 p.
 article
47 II.P8 Have patients with Parkinson's Disease in H&Y-stage III the ability to acquire implicit sequence knowledge? Kerckhofs, E.
 2006
 12 S1 p. 26-27
2 p.
 article
48 II.P2 Mental dysfunction in patients with vascular parkinsonism compared to patients with Parkinson Disease Štenc Bradvica, I.
 2006
 12 S1 p. 25-
1 p.
 article
49 II.P1 Mild cognitive impairment in Parkinson's Disease - an MRI study Beyer, M.
 2006
 12 S1 p. 25-
1 p.
 article
50 II.P4 Neuropsychological differences between mild cognitive impairment patients with and without Parkinson's Disease Petrova, M.
 2006
 12 S1 p. 25-26
2 p.
 article
51 II.P16 Osteopontin is elevated in Parkinson's Disease (PD) and PD with dementia Maetzler, W.
 2006
 12 S1 p. 29-
1 p.
 article
52 II.P14 Parkinson's Disease Dementia as a distinct neurobiological entity: insights from postmortem human brains Piccoli, G.
 2006
 12 S1 p. 28-
1 p.
 article
53 II.P12 Predictors of cognitive deterioration in Parkinson's Disease Stepkina, D.
 2006
 12 S1 p. 28-
1 p.
 article
54 II.P7 The role of cognitive mechanisms in sentence comprehension in Dutch speaking Parkinson's Disease patients: preliminary data Colman, K.
 2006
 12 S1 p. 26-
1 p.
 article
55 II.P19 The use of electroencephalograhy in the differential diagnosis between Alzheimer's disease and dementia with Lewy bodies Roks, G.
 2006
 12 S1 p. 29-30
2 p.
 article
56 II.5 The role of acetylcholine in Parkinson's Disease-related cognitive dysfunction Emre, M.
 2006
 12 S1 p. 6-
1 p.
 article
57 II.4 The role of dopamine in Parkinson's Disease-related cognitive dysfunction Kulisevsky, J.
 2006
 12 S1 p. 5-6
2 p.
 article
58 II.6 The role of serotonin in Parkinson's Disease-related cognitive dysfunction Leentjens, A.F.G.
 2006
 12 S1 p. 6-
1 p.
 article
59 I.2 Neuro-anatomical concepts on motion and emotion Groenewegen, H.J.
 2006
 12 S1 p. 1-
1 p.
 article
60 I.3 Neuropathological correlates of mental dysfunction in Parkinson's Disease van de Berg, W.
 2006
 12 S1 p. 1-
1 p.
 article
61 Introduction Wolters, E.Ch.
 2006
 12 S1 p. v-
1 p.
 article
62 I.P13 Age related changes in DJ-1 deficient mice Chandran, J.S.
 2006
 12 S1 p. 24-
1 p.
 article
63 I.7 Pain in Parkinson's Disease Scherder, E.
 2006
 12 S1 p. 2-
1 p.
 article
64 I.P3 A study of sensorimotor filtering in “de novo” Parkinson Disease Perriol, M.P.
 2006
 12 S1 p. 21-
1 p.
 article
65 I.P1 Depression and cognitive impairment in patiens with Parkinson's Disease in university clinical centre of Belgrade Dzoljic, E.
 2006
 12 S1 p. 21-
1 p.
 article
66 I.P12 Double vision in Parkinson's Disease Nebe, A.
 2006
 12 S1 p. 24-
1 p.
 article
67 I.P9 Effect of visuo-spatial cues on language processing in Parkinson's Disease Patients Wattendorf, E.
 2006
 12 S1 p. 23-
1 p.
 article
68 I.P8 Incessant drawing in a patient with advanced stage Parkinson Disease Shibayama, H.
 2006
 12 S1 p. 23-
1 p.
 article
69 I.P10 Measurement of rigidity in elbow joint: An objective method for evaluation of rigidity involved diseases Sepehri, B.
 2006
 12 S1 p. 23-
1 p.
 article
70 I.P11 Pain is a common nonmotor symptom Nebe, A.
 2006
 12 S1 p. 23-
1 p.
 article
71 I.P2 Prevalence of non motor symptoms in Parkinson's Disease: An international survey using NMSQuest in 525 patients Clayton, L.
 2006
 12 S1 p. 21-
1 p.
 article
72 I.P6 Prospective study of risk factors for neuropsychiatric disturbances in patients with Parkinson's Disease Smiljkovic, T.
 2006
 12 S1 p. 22-
1 p.
 article
73 I.P5 Psychiatric disturbances in patients with Parkinson's Disease Potic, J.
 2006
 12 S1 p. 22-
1 p.
 article
74 I.P7 Relationship between Parkinson's Disease and Restless legs syndrome Nomura, T.
 2006
 12 S1 p. 22-
1 p.
 article
75 I.P4 Reversal of drug-induced pathological gambling in PD patients treated with subthalamic nucleus stimulation Ardouin, C.
 2006
 12 S1 p. 22-
1 p.
 article
76 I.P15 The predictive value of olfactory dysfunction and cognitive dysfunction for preclinical Parkinson's Disease Ponsen, M.M.
 2006
 12 S1 p. 24-25
2 p.
 article
77 I.P14 The sensitivity and specificity of Weigl's Colour Form Sorting Test‚ as a cognitive screen in Parkinson's Disease patients and age/gender matched elderly controls Hobson, P.
 2006
 12 S1 p. 24-
1 p.
 article
78 I.9 Sleep disorders in Parkinson's Disease Chaudhuri, K.R.
 2006
 12 S1 p. 3-
1 p.
 article
79 I.10 The epidemiology of mental dysfunction in Parkinson's Disease Aarsland, D.
 2006
 12 S1 p. 3-
1 p.
 article
80 I.11 The impact of mental dysfunction in Parkinson's Disease Verbaan, D.
 2006
 12 S1 p. 3-
1 p.
 article
81 I.1 The problem of dementia in Parkinson's Disease Calne, D.B.
 2006
 12 S1 p. 1-
1 p.
 article
82 IV.12 Biochemical basis of psychosis in Parkinson's Disease Riederer, P.
 2006
 12 S1 p. 14-15
2 p.
 article
83 IV.1 Current treatment of Parkinson's Disease Stocchi, F.
 2006
 12 S1 p. 12-
1 p.
 article
84 IV.16 Deep brain stimulation in mood disorders Lozano, A.M
 2006
 12 S1 p. 15-16
2 p.
 article
85 IV.15 Deep brain stimulation in neurodegenerative diseases Benabid, A.
 2006
 12 S1 p. 15-
1 p.
 article
86 IV.9 Epidemiology of major depression - how is the view changing? Schlaepfer, T.E.
 2006
 12 S1 p. 13-14
2 p.
 article
87 IV.11 Epidemiology of psychosis in Parkinson's Disease Aarsland, D.
 2006
 12 S1 p. 14-
1 p.
 article
88 IV.17 Future developments in the treatment of Parkinson's Disease: a case for multifunctional drugs Youdim, M.B.H.
 2006
 12 S1 p. 16-
1 p.
 article
89 IV.2 Future symptomatic treatments of Parkinson's Disease Jenner, P.
 2006
 12 S1 p. 12-
1 p.
 article
90 IV.10 How to treat psychotic depression in a patient with Parkinson's disease? Nolen, W.A.
 2006
 12 S1 p. 14-
1 p.
 article
91 IV.7 Other treatment approaches Burn, D.J.
 2006
 12 S1 p. 13-
1 p.
 article
92 IV.P6 Cueing therapy in the home environment of patients with Parkinson's Disease: effects on ambulatory physical activity in the RESCUE trial van Wegen, E.
 2006
 12 S1 p. 34-
1 p.
 article
93 IV.P10 Does deep brain stimulation for Parkinson's Disease increase depression? Roane, D.M.
 2006
 12 S1 p. 35-
1 p.
 article
94 IV.P2 Dopamine amide conjugates as potent anti-Parkinson's agents Nayak, A.
 2006
 12 S1 p. 33-
1 p.
 article
95 IV.P8 Effect of active contact location in STN DBS on spatial working memory performance in Parkinson's Disease (PD) Campbell, M.
 2006
 12 S1 p. 35-
1 p.
 article
96 IV.P3 Effects of dopamine agonist Pramipexole on executive functions in fluctuating Parkinson's Disease patients Nodel, M.
 2006
 12 S1 p. 33-
1 p.
 article
97 IV.P5 Efficacy of a group physical therapy program in patients with Parkinson's Disease: a randomized controlled trial de Goede, C.
 2006
 12 S1 p. 34-
1 p.
 article
98 IV.P9 No change in mood but increase in apathy in Parkinson's Disease patients treated by subthalamic nucleus stimulation Lhomméme, E.
 2006
 12 S1 p. 35-
1 p.
 article
99 IV.P1 Nocturnal “wearing off” symptoms in levodopa treated Parkinson's Disease: an under-recognised phenomenon Holmes, R.
 2006
 12 S1 p. 33-
1 p.
 article
100 IV.P13 Porcine tissues influence kynurenic acid formation Baran, H.
 2006
 12 S1 p. 36-
1 p.
 article
101 IV.P11 Subthalamic nucleus (STN) deep brain stimulation (DBS) and the non-motor symptom scale (NMSS) in Parkinson's Disease (PD) Simkin, S.
 2006
 12 S1 p. 35-36
2 p.
 article
102 IV.P7 The effect of external cueing with a prototype cueing device in a Parkinson patient with severe on-freezing:a case study Burgers-Bots, I.
 2006
 12 S1 p. 34-
1 p.
 article
103 IV.P12 The influence of dopaminomimetics on resting state functional connectivity in Parkinson's Disease: an MEG study Stoffers, D.
 2006
 12 S1 p. 36-
1 p.
 article
104 IV.P4 Treatment with cholinesterase inhibitors in supranuclear palsy: a preliminary case-series Liepelt, I.
 2006
 12 S1 p. 33-34
2 p.
 article
105 IV.8 Recent advances in pharmacodynamics of antidepressants - are they of immediate clinical relevance? Müller, W.E.
 2006
 12 S1 p. 13-
1 p.
 article
106 IV.4 Stem cells, viral vectors and other neurorestorative treatments Deierborg, T.
 2006
 12 S1 p. 12-
1 p.
 article
107 IV.3 Surgical approaches to Parkinson's Disease Benabid, A.
 2006
 12 S1 p. 12-
1 p.
 article
108 IV.14 The neural response to transcranial magnetic stimulation of the human motor cortex in patients with Parkinson's Disease van der Werf, Y.D.
 2006
 12 S1 p. 15-
1 p.
 article
109 IV.13 Therapy of psychosis in Parkinson's Disease Korczyn, A.D.
 2006
 12 S1 p. 15-
1 p.
 article
110 IV.5 The role of the dopaminergic system in dementia associated with Parkinson's Disease Kulisevsky, J.
 2006
 12 S1 p. 12-13
2 p.
 article
111 IV.6 Treatment with cholinesterase inhibitors Emre, M.
 2006
 12 S1 p. 13-
1 p.
 article
112 5th International Congress on Mental Dysfunction in Parkinson's Disease 2006
 12 S1 p. vi-
1 p.
 article
113 5th International Congress on Mental Dysfunction in Parkinson's Disease Programme 2006
 12 S1 p. vii-ix
nvt p.
 article
114 V.9 Cognitive dysfunction and dementia in Parkinson's Disease: EEG/MEG experience Bosboom, J.L.W.
 2006
 12 S1 p. 19-20
2 p.
 article
115 V.4 DAT-SCAN in Parkinson's Disease and multiple system atrophy/progressive supranuclear palsy Booij, J.
 2006
 12 S1 p. 18-
1 p.
 article
116 V.6 Dopaminergic modulation of cognitive flexibility: the role of the striatum Cools, R.
 2006
 12 S1 p. 19-
1 p.
 article
117 V.5 Dopamine transporter imaging in Alzheimer's Disease, Parkinson's Disease Dementia, and Lewy body Dementia Grosset, D.
 2006
 12 S1 p. 18-19
2 p.
 article
118 V.7 fMRI studies of psychosis in Parkinson's Disease Goetz, C.G.
 2006
 12 S1 p. 19-
1 p.
 article
119 V.3 Imaging of BBB function and inflammation Leenders, K.L.
 2006
 12 S1 p. 18-
1 p.
 article
120 V.2 Imaging of the cholinergic system in Parkinson's Disease Remy, P.
 2006
 12 S1 p. 18-
1 p.
 article
121 V.1 Imaging of the dopaminergic system in Parkinson's Disease Brooks, D.J.
 2006
 12 S1 p. 18-
1 p.
 article
122 V.8 Neurophysiology of motor behaviour Brown, P.
 2006
 12 S1 p. 19-
1 p.
 article
123 V.10 The neurophysiology of dementia in Parkinson's Disease: does connectivity count? Stam, C.J.
 2006
 12 S1 p. 20-
1 p.
 article
                             123 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands